Testing for Diabetes Insipidus
Suspect diabetes insipidus in patients with polyuria, polydipsia, and inappropriately dilute urine (osmolality <200 mOsm/kg H₂O) in the presence of elevated serum osmolality (>300 mOsm/kg H₂O) or hypernatremia, and proceed directly to measure serum sodium, serum osmolality, and urine osmolality as the initial biochemical workup 1.
Initial Clinical Assessment
Look specifically for:
- In children: polyuria, polydipsia, failure to thrive, hypernatremic dehydration, feeding difficulties, vomiting 1
- In adults: unexplained polydipsia and polyuria (typically >3 L/day), nocturia 1, 2
- In infants: particularly high risk as they cannot self-regulate fluid intake and may present with dehydration 1
The mean age at diagnosis is approximately 4 months for congenital cases, with serum osmolality usually >300 mOsm/kg H₂O and urine osmolality typically <200 mOsm/kg H₂O (though can be higher in milder cases) 1.
Diagnostic Algorithm
Step 1: Basic Biochemical Testing
Measure simultaneously:
- Serum sodium
- Serum osmolality
- Urine osmolality 1
Diagnostic threshold: The combination of urine osmolality <400 mOsm/kg and serum osmolality >302 mOsm/kg achieves 90% sensitivity and 98% specificity for diabetes insipidus 3.
Step 2: Water Deprivation Test (When Needed)
The traditional water deprivation test has significant limitations and may not be necessary in all cases 4, 5. However, when performed:
Simplified protocol 3:
- Begin after 12 hours of overnight fasting
- Continue fluid deprivation for approximately 5 hours (median duration)
- Monitor weight, urine osmolality, serum osmolality
- Stop when:
3% weight reduction
- Urine specific gravity >1.020 or urine osmolality >800 mOsm/L
- Intolerable symptoms (excessive thirst)
Critical pitfall: The short water deprivation test has limited diagnostic value—approximately 26% of patients diagnosed with primary polydipsia may actually have partial diabetes insipidus that was missed 6. Extended testing (14-24 hours) may be required 6.
Step 3: Desmopressin Challenge
After water deprivation, administer desmopressin to differentiate:
- Central DI: Urine osmolality increases significantly (>50% rise) 7, 2
- Nephrogenic DI: Minimal or no response to desmopressin 7
- Primary polydipsia: Urine already concentrated from water deprivation 5
Step 4: Advanced Testing (When Available)
Copeptin measurement offers superior diagnostic accuracy compared to traditional water deprivation testing 4, 5:
- Measured during hypertonic saline stimulation
- More stable and easier to measure than direct AVP
- In adults: Plasma copeptin <21.4 pmol/L suggests AVP deficiency (central DI) and warrants further testing with hypertonic saline or arginine infusion 1
- Does not overlap between primary polydipsia and central DI 6
Important limitation: Copeptin testing is not routinely available in most centers and pediatric data are limited 1, 2.
Distinguishing Between Types
Central vs. Nephrogenic DI
- Central DI: Responds to desmopressin 7, 2
- Nephrogenic DI: No response to desmopressin; desmopressin is ineffective for nephrogenic DI 7
- Genetic testing: Recommended early in suspected nephrogenic DI cases, particularly testing AVPR2 and AQP2 genes in symptomatic patients 1
DI vs. Primary Polydipsia
- Primary polydipsia: Responds to water deprivation with urine concentration 5
- DI: Fails to concentrate urine despite water deprivation 4
- Urinary AVP measurement (when available) shows excellent discrimination—no overlap between primary polydipsia and central DI 6
Common Diagnostic Pitfalls
Partial DI: May produce equivocal results on water deprivation testing; consider extended testing duration 6
Nasal mucosa changes: Scarring, edema, or disease can cause erratic absorption of intranasal desmopressin, making diagnostic testing unreliable 7
Mimics to exclude 2:
- Poorly controlled diabetes mellitus (high urine osmolality, hyperglycemia, glucosuria)
- Pheochromocytoma
- Secondary inherited causes (Bartter syndrome, distal RTA, nephronophthisis)
Stopping test prematurely: Many patients with primary polydipsia (26%) do not reach diagnostic thresholds on short testing 6
Post-Diagnosis Workup
Once biochemical diagnosis is confirmed:
- Imaging: MRI of pituitary/hypothalamus to identify structural causes 2, 5
- Genetic testing: Strongly recommended in congenital cases, using accredited diagnostic laboratories 1
- Etiology assessment: Determine if central (pituitary pathology, trauma, surgery) or nephrogenic (genetic, acquired) 1, 2
For nephrogenic DI specifically: Early genetic testing is strongly recommended, including testing of umbilical cord blood in male offspring of known AVPR2 mutation carriers 1.